Detailansicht

Wissensnetz

Person

Rosemarie Marchan

Toxikologin

Name	Rosemarie Marchan
Ort	Deutschland USA
Geschlecht	weiblich
Akademischer Grad bzw. Titel	Dr.
Beruf	Toxikologin (charakteristischer Beruf)
Beziehung	Technische Universität Dortmund. Leibniz-Institut für Arbeitsforschung (2008-) (Wissenschaftliche Mitarbeiterin, Leiterin der Nachwuchsgruppe Zelluläre Toxikologie)
Weitere Angaben	Studium der Umweltwissenschaften und der Biologie, Promotion 2007 in den USA
Quelle	Homepage: http://www.ifado.de/toxikologie/mitarbeiter/rosemarie-marchan/ (23.11.2017)
Datensatztyp	Person
GND-Nummer	1145185959
Datensatz-ID	1145185959
Beteiligt an alle anzeigen Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic Targets The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations Adverse outcome pathways: opportunities, limitations and open questions Adverse outcome pathways : opportunities, limitations and open questions Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Rosemarie Marchan

Inhibiting the glycerophosphodiesterase EDI3 in ER-HER2+ breast cancer cells resistant to HER2-targeted therapy reduces viability and tumour growth

Metabolic Profiling of Thymic Epithelial Tumors Hints to a Strong Warburg Effect, Glutaminolysis and Precarious Redox Homeostasis as Potential Therapeutic Targets

The hepatocyte export carrier inhibition assay improves the separation of hepatotoxic from non-hepatotoxic compounds

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Prediction of human drug-induced liver injury (DILI) in relation to oral doses and blood concentrations

Adverse outcome pathways: opportunities, limitations and open questions

Adverse outcome pathways : opportunities, limitations and open questions

Highlight report : towards the replacement of in vivo repeated dose systemic toxicity testing